Michael W. Otto, Ph.D., is Professor in the Department of Psychological and Brain Sciences and Director of the Translational Research Program at Boston University. He has had a major career focus on developing and validating new psychosocial treatments, with a focus on treatment refractory populations including those with bipolar, anxiety, and substance use disorders. His work includes a translational research agenda investigating brain-behavior relationships in therapeutic learning, including the use of novel strategies (e.g., d-cycloserine, yohimbine) to improve the consolidation of therapeutic learning. Dr. Otto’s focus on hard-to-treat conditions and principles underlying behavior-change failures led him to an additional focus on health-behavior promotion, including investigations of addictive behaviors, medication adherence, sleep, and exercise. Across these behaviors, he has been concerned with cognitive, attention, and affective factors that derail adaptive behaviors. Likewise, he is experienced with neuropsychological investigations and outcome trials in those with major mental disorders. Dr. Otto has published over 400 articles and over 20 books spanning his research interests, and he Dr. Otto was identified as a “top producer” in the clinical empirical literature as well as an ISI Highly Cited Researcher. His leadership positions include serving as Past President of the Association of Behavioral and Cognitive Therapies, and immediate Past President of Division 12 of the American Psychological Association.
To contact GME, email us at [email protected]